blog | Attovia Therapeutics

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, Attovia Therapeutics

Attovia Therapeutics (ATTO) Targets $200 Million IPO to Advance Next-Generation Biologics for Immune-Mediated Diseases

Eric Friedman

Jul 31, 2026, 3:12:40 PM

Attovia Therapeutics (NASDAQ: ATTO) has filed to raise approximately $200 million through an initial...

Subscribe to our Newsletter

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025